Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

1997
2025

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 1
1998 3
1999 5
2000 4
2001 1
2005 1
2006 2
2008 3
2010 1
2012 1
2013 4
2014 2
2015 1
2016 1
2017 1
2018 5
2019 4
2020 5
2021 2
2022 3
2023 6
2024 2
2025 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

54 results

Results by year

Filters applied: . Clear all
Page 1
NCCN Guidelines Insights: Acute Myeloid Leukemia, Version 2.2021.
Pollyea DA, Bixby D, Perl A, Bhatt VR, Altman JK, Appelbaum FR, de Lima M, Fathi AT, Foran JM, Gojo I, Hall AC, Jacoby M, Lancet J, Mannis G, Marcucci G, Martin MG, Mims A, Neff J, Nejati R, Olin R, Percival ME, Prebet T, Przespolewski A, Rao D, Ravandi-Kashani F, Shami PJ, Stone RM, Strickland SA, Sweet K, Vachhani P, Wieduwilt M, Gregory KM, Ogba N, Tallman MS. Pollyea DA, et al. Among authors: ravandi kashani f. J Natl Compr Canc Netw. 2021 Jan 6;19(1):16-27. doi: 10.6004/jnccn.2021.0002. J Natl Compr Canc Netw. 2021. PMID: 33406488
Hematologic malignancies and Li-Fraumeni syndrome.
Swaminathan M, Bannon SA, Routbort M, Naqvi K, Kadia TM, Takahashi K, Alvarado Y, Ravandi-Kashani F, Patel KP, Champlin R, Kantarjian H, Strong L, DiNardo CD. Swaminathan M, et al. Among authors: ravandi kashani f. Cold Spring Harb Mol Case Stud. 2019 Feb 1;5(1):a003210. doi: 10.1101/mcs.a003210. Print 2019 Feb. Cold Spring Harb Mol Case Stud. 2019. PMID: 30709875 Free PMC article. Review.
CPX-351 (vyxeos) in AML.
Alfayez M, Kantarjian H, Kadia T, Ravandi-Kashani F, Daver N. Alfayez M, et al. Among authors: ravandi kashani f. Leuk Lymphoma. 2020 Feb;61(2):288-297. doi: 10.1080/10428194.2019.1660970. Epub 2019 Sep 24. Leuk Lymphoma. 2020. PMID: 31547736 Review.
Oral Azacitidine Maintenance Therapy for Acute Myeloid Leukemia in First Remission.
Wei AH, Döhner H, Pocock C, Montesinos P, Afanasyev B, Dombret H, Ravandi F, Sayar H, Jang JH, Porkka K, Selleslag D, Sandhu I, Turgut M, Giai V, Ofran Y, Kizil Çakar M, Botelho de Sousa A, Rybka J, Frairia C, Borin L, Beltrami G, Čermák J, Ossenkoppele GJ, La Torre I, Skikne B, Kumar K, Dong Q, Beach CL, Roboz GJ; QUAZAR AML-001 Trial Investigators. Wei AH, et al. N Engl J Med. 2020 Dec 24;383(26):2526-2537. doi: 10.1056/NEJMoa2004444. N Engl J Med. 2020. PMID: 33369355 Clinical Trial.
IDH1/IDH2 Inhibition in Acute Myeloid Leukemia.
Cerchione C, Romano A, Daver N, DiNardo C, Jabbour EJ, Konopleva M, Ravandi-Kashani F, Kadia T, Martelli MP, Isidori A, Martinelli G, Kantarjian H. Cerchione C, et al. Among authors: ravandi kashani f. Front Oncol. 2021 Mar 29;11:639387. doi: 10.3389/fonc.2021.639387. eCollection 2021. Front Oncol. 2021. PMID: 33898313 Free PMC article. Review.
Non-intensive acute myeloid leukemia therapies for older patients.
Babakhanlou R, Ravandi-Kashani F. Babakhanlou R, et al. Among authors: ravandi kashani f. Expert Rev Hematol. 2023 Mar;16(3):171-180. doi: 10.1080/17474086.2023.2184342. Epub 2023 Mar 2. Expert Rev Hematol. 2023. PMID: 36864772 Review.
The pharmacological management of hairy cell leukemia.
Ramos Perez J, Ravandi-Kashani F. Ramos Perez J, et al. Among authors: ravandi kashani f. Expert Opin Pharmacother. 2020 Aug;21(11):1337-1344. doi: 10.1080/14656566.2020.1754397. Epub 2020 May 7. Expert Opin Pharmacother. 2020. PMID: 32378970 Review.
Outcomes of patients with acute myeloid leukemia and bone marrow fibrosis.
Urrutia S, Kantarjian HM, Ravandi-Kashani F, Bueso-Ramos C, Kanagal-Shamanna R, Jabbour E, Montalban-Bravo G, Short NJ, Daver N, Borthakur G, Dinardo CD, Kadia TM, Masarova L, Bose P, Pemmaraju N, Garcia-Manero G, Sasaki K. Urrutia S, et al. Among authors: ravandi kashani f. J Hematol Oncol. 2024 Nov 15;17(1):112. doi: 10.1186/s13045-024-01630-w. J Hematol Oncol. 2024. PMID: 39548557 Free PMC article.
54 results